GLP-1 receptor agonists, such as Semaglutide and Ozempic, mimic the action of this hormone, leading to improved blood sugar control and other metabolic benefits
Moreover, some benefits on clinical and metabolic features of PCOS may not have fully emerged due to the low or medium doses employed in the vast majority of the current studies
Semaglutide decreases IL-6 and TNF- levels inflammatory mediators that, when chronically elevated, contribute to both metabolic dysfunction and poor sleep quality
These are non-negotiable inputs, not optional optimizations
doi: 10.1016/j.jdiacomp.2019.05.016 46 IwakuraYNakaeSSaijoSIshigameH
You cannot simply swap one for the other at equivalent doses, as the mechanisms differ